Abstract
Idiopathic thrombocytopenic purpura is not an uncommon bleeding disorder with a prevalence of 40–80 per million children per year. Over the last six decades, the subject of ITP has attracted the attention of pediatricians and hematologists. It is one of the subjects which has many controversies because of its unpredictable course heralded by remission relapses, and chronicity with mortality in less than 1% of cases. In the present review only the controversies in the management of acute and chronic ITP have been reviewed as it interests most pediatricians. Management of intracranial hemorrhage (ICH), severe gastrointestinal hemorrhage and menorrhagia continues to still remain a challenge in spite of newer therapies.
Similar content being viewed by others
References
Beardsley DS. Platelet abnormalities in infancy and childhood. In: Nathan DG, and Oski FA, eds.Hematology of infancy and childhood 4 ed. WB Saunders Company Philadidlpua 1993; 1561–1604.
Dubansky AS and Oski FA. Controversies in the management of acute idiopathic thrombocytopenic purpura. A survey of specialists.Pediatrics 1986; 77: 49–52.
Buchanan GR. Childhood ITP: How many tests and how much treatment required.J Pediatr 1985; 106: 928–930.
Buchanan GR, and Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial.Am J Pediatr Hematol Oncol 1984; 6: 355–361.
Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in childhood. Preliminary results of a randomized cooperative study.Am J Pediatr Hematol Oncol 1984; 6: 165–169.
von dem Borne AE and Vod JJ,et al. High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia.Br Med J (Clin Res) 1988; 269: 249.
Imbach P, D’Apuzzo V, Hirt Aet al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.Lancet 1981; 1: 1228–1230.
Imbach P, Berchtold W, Hirt A,et al. Intravenous IgG versus oral corticosteroids in acute immune thrombocytopenic purpura of childhood.Lancet 1985; 11: 464–468.
Blanchette VS, Luke B, Andrew M,et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.J Pediatr 1993; 123: 989–995.
Albayrak D, Islek I, Kelayee AG,et al. Acute immune thrombocytopenic purpura. A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 1994; 125: 1004–1007.
Blanchette VS, Imbach P, Andrew Met al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisolone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703–707.
Krishnamurti L, Charan VD, Desai N, Pati H and Choudhry VP. Anti D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.Ind J Pediatr 1994; 61: 179.
Medeiros D and Buchanan R. Current controversies in the management of idiopathic thrombocytopenic purpura.Ped Clin N Amer 1996; 43: 757–772.
Bussel JB, Graziano JN, Kimberly RPet al. Intravenous anti-D treatment of immune thrombocytopenic purpura. Analysis of efficacy, toxicity, and mechanism of effect.Blood 1991; 77: 1884–1893.
Schreiber AD, Chien P, Tomaski A, Cines DB. Effect of danazol in immune thrombocytopenic purpura.N Engl J Med 1987; 316: 503–508.
Choudhry VP, Kashyap R, Ahlawat S, Pati HP. Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic purpura.Int J Hematol 1995; 61: 157–162.
Proctor SJ, Jackson G, Carey Pet al. Improvement of platelet count in steroid unresponsive idiopathic immune thrombocytopenic purpura after short course therapy with recombinant alpha-2b interferon.Blood 1989; 74: 1894–1897.
Godeau B, Oksenbendler E, Ier Ling P. Dapsone for autoimmune thrombocytopenic purpura.Am J Hematol 1993; 49: 70–72.
Belak M, Widder RA, Brunner Ret al. Immunoadsorption with protein a Sepharose of silica.Lancet 1994; 343: 792–793.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Choudhry, V.P., Kashyap, R. & Pati, H.P. Management of idiopathic thrombocytopenic purpura. Indian J Pediatr 65, 401–407 (1998). https://doi.org/10.1007/BF02761134
Issue Date:
DOI: https://doi.org/10.1007/BF02761134